MicroPort Scientific Corporation

Equities

853 KYG608371046

Advanced Medical Equipment & Technology

Market Closed - Hong Kong S.E. Other stock markets 04:08:17 2024-05-17 am EDT			5-day change	1st Jan Change
7.08 ^HKD	-0.28%		+0.43%	-15.91%

May. 01	MicroPort Scientific's 2023 Loss Widens Despite Revenue Growth	MT
Apr. 09	Nomura Adjusts MicroPort Scientific’s Price Target to HK$6.71 From HK$7.19, Keeps at Neutral	MT

MicroPort Scientific Corporation Provides Earninsgs Guidance for the Twelve Months Ended 31 December 2020

February 26, 2021 at 09:48 am EST

The board of directors of MicroPort Scientific Corporation informed holders of the company's shares and securities and potential investors that, based on unaudited consolidated financial statements currently available to the Board, the Group has recorded a loss attributable to equity shareholders of the company for the twelve months ended 31 December 2020 of between USD 188 million and USD 203 million, as compared with a profit of approximately USD 46.3 million for the same period of last year.

Latest news about MicroPort Scientific Corporation

MicroPort Scientific's 2023 Loss Widens Despite Revenue Growth	May. 01	MT
Nomura Adjusts MicroPort Scientific’s Price Target to HK$6.71 From HK$7.19, Keeps at Neutral	Apr. 09	MT
MicroPort Scientific to Receive $150 Million Loan Facility, $300 Million Credit Support to Repay Convertible Bonds	Apr. 08	MT
MicroPort Scientific Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Nomura Adjusts MicroPort Scientific’s Price Target to HK$7.19 From HK$17.59, Keeps at Neutral	Mar. 06	MT
MicroPort Scientific Corporation Provides Earnings Guidance for the Year Ended 31 December 2023	Mar. 05	CI
MicroPort Scientific Corporation Reports Revenue Results for the Twelve Months Ended 31 December 2023	Mar. 05	CI
MicroPort Scientific Unit to See Up to 38% Boost in 2023 Profit	Jan. 30	MT
MicroPort Scientific Raises $220 Million from Convertible Bond Issue; To Buy Back, Cancel $217 Million of Existing Bonds	Dec. 20	MT
Otsuka's Unit Remains as MicroPort Scientific's Thai Distributor Until 2026	Dec. 18	MT
EV MedTech Raises 1.8 Billion Yuan from Placement	Dec. 14	MT
MicroPort Scientific Says Businesses Maintain Steady Growth	Dec. 11	MT
MicroPort Launches Tender Offer for Zero-Coupon Bonds Due 2026; To Issue New Debts Worth $220 Million	Dec. 06	MT
MicroPort Scientific Names Dealer Managers for $700 Million Convertible Bond Buyback; Shares Plunge 19%	Dec. 05	MT
Microport Neurotech Limited and Microport Scientific Corporation Agrees to Renew the 2022 Master Materials Procurement Agreement, the 2022 Master Supporting Services Procurement Agreement and the 2022 Master Catering Services Agreement	Dec. 01	CI
MicroPort Scientific Corporation Announces Appointment of Peng Bo as Non-Executive Director and Member of the Strategic Committee	Nov. 10	CI
Shanghai MicroPort Endovascular MedTech's Profit Up 29% in Q1-Q3	23-10-30	MT
Shanghai Microport MedBot Gets Thumbs Up to Launch Toumai Surgical Robot	23-10-26	MT
MicroPort Scientific's Loss Narrows in H1	23-08-31	MT
MicroPort Scientific Corporation Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
MicroPort Scientific Corporation Announces Board Changes	23-08-30	CI
Shanghai MicroPort Endovascular MedTech's H1 Attributable Profit Increases 30%	23-08-28	MT
Nomura Adjusts Microport's Price Target to HK$17.59 From HK$23.24, Keeps at Neutral	23-08-01	MT
Shanghai Bourse Approves EV MedTech's Proposed Share Issuance	23-07-13	MT
EV MedTech Expects Up to 30% Increase in First-Half Profit	23-07-11	MT

Chart MicroPort Scientific Corporation

Duration

Period

More charts

Company Profile

MicroPort Scientific Corporation is a Hong Kong-based investment holding company principally engaged in the manufacture and sales of medical products. The Company operates through seven segments. Orthopedics Devices segment researches, develops, manufactures and sells orthopedics devices. Cardiovascular Devices segment researches, develops, manufactures and sells cardiovascular devices, such as drug eluting stents. Endovascular Devices segment researches, develops, manufactures and sells endovascular devices. Electrophysiology Devices segment researches, develops, manufactures and sells electrophysiology devices. Neurovascular Devices segment researches, develops, manufactures and sells neurovascular devices. Surgical Management segment researches, develops, manufactures and sells surgical devices. Diabetes Care and Endocrinal Management segment researches, develops, manufactures and sells devices related to diabetes mellitus.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-28 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for MicroPort Scientific Corporation

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.9075 USD

Average target price

1.616 USD

Spread / Average Target

+78.12%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
MICROPORT SCIENTIFIC CORPORATION	-15.91%	1.66B
THERMO FISHER SCIENTIFIC	+12.15%	227B
DANAHER CORPORATION	+14.90%	197B
INTUITIVE SURGICAL, INC.	+18.22%	141B
BOSTON SCIENTIFIC CORPORATION	+29.15%	110B
SIEMENS HEALTHINEERS AG	+0.53%	64.15B
EDWARDS LIFESCIENCES CORPORATION	+16.92%	53.72B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+6.33%	51.75B
AGILENT TECHNOLOGIES, INC.	+10.93%	45.2B
GE HEALTHCARE TECHNOLOGIES INC.	+5.87%	37.37B

Other Advanced Medical Equipment & Technology